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1. Introduction 
Children and adolescents can have a variety of psychotic disorders from acute and 
transitory psychoses to chronic ones, such as schizophrenia. Their psychotic 
symptomatology, however, can also be the consequence of an organic cause or drug-
inducted. Comparing to adolescence and adulthood, psychotic disorders in childhood seem 
to occur more rarely, which can be explained by lower incidence and diagnostic problems - 
hallucinations and delusions in children are quite difficult to recognise (Turk et al., 2007).  
While schizophrenia is a very rare disorder in childhood, it becomes increasingly common 
during adolescence. It is actually the most frequent psychotic disorder in the age group of 
more than 12 years. This is the reason why this chapter will discuss schizophrenia in greater 
detail, highlighting possible difficulties a therapist can face during a diagnostic process. 
Some of these diagnostic difficulties will also be emphasized by the case report describing a 
metabolic disease which can mimic schizophrenia symptoms. 
Even though childhood and adolescent schizophrenia lie on a continuum with 
schizophrenia in adults and the same diagnostic criteria are valid no matter the age group, 
there are special difficulties in applying the adult criteria to children. Symptoms at an early 
stage are less specific and in addition show remarkable overlap with a number of 
developmental disorders. So, diagnosing schizophrenia in children or adolescents could be a 
much harder task than diagnosing adults. 
In childhood and adolescence, schizophrenia most often has a slow and insidious onset with 
many precursors in the shape of developmental, cognitive and emotional symptoms or 
retardation. None of these precursors is schizophrenia-specific, therefore it is striking to see 
the number of children and adolescents with schizophrenia that seem to be 
multidimensionally impaired.  
The fact is that schizophrenic psychoses are a very heterogeneous group of disorders. 
Consequently, it is difficult to find a unique etiology. Studies in recent years have focused 
on the neurobiological and neurodevelopmental approaches, including genetics, and have 
produced interesting results which have not been yet integrated into conclusive and 
convincing theory of schizophrenia (Remschmidt, 2001).  
The prognosis of early-onset schizophrenia is worse than schizophrenia that starts in 
adulthood, hence early recognition and treatment is crucial. Children and adolescents  
with any psychotic disorder, especially with schizophrenia, thus require a broad, 
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multidimensional treatment approach, very often including hospital treatment, with the 
focus on the socialization and rehabilitation. Pharmacotherapy does not differ a lot from 
adult patients. 
As it will be seen in a case report and afterwards discussion the importance of excluding 
possible organic causes, whose clinical manifestation can mimic a psychotic disorder, can 
not be overestimated. Thus careful clinical, laboratory and imaging diagnostic evaluation 
must always be performed. 
2. History of psychotic disorders in childhood and adolescence 
The term psychosis was used very broadly in children and adolescents. It also covered the 
children with behavioural and autistic spectrum symptoms. The clinical distinction between 
autism and other psychotic disorders was first established by Kolvin in 1971 (Kolvin, 1971), 
but there is still confusion and misdiagnosis between the two disorders. The presence of 
fleeting hallucinations and delusions in nonpsychotic children can also be often misleading 
in a variety of other diagnoses, such as acute or reactive psychosis. But the onset of 
schizophrenia during adolescence and childhood has been accepted already in the twentieth 
century, and it is even more today. The child, adolescent and adult forms of schizophrenia 
could be regarded as a qualitatively similar and continuous, while allowing for 
developmental variation (Remschmidt, 2001).  
3. Classification of psychotic disorders 
Psychotic disorders can be classified into (modified after Turk et al., Turk, 2007): 
- acute and transitory psychotic disorders 
- schizophrenia 
- organic psychotic disorders or psychotic disorders due to general medical condition 
- substance-induced psychotic disorders  
- schizoaffective disorders. 
In schizoaffective disorders, symptoms of schizophrenia and affective symptoms are present 
at the same time. Since they are very rare in children and adolescents, they will not be 
considered in detail here. Psychotic symptoms, on the other hand, can be found in 58% of 
patients with bipolar disorder (see the subchapter 5.6 Differential Diagnosis of 
schizophrenia for more detail), which is classified under affective disorders. 
4. Developmental aspects of psychotic disorders 
Main characteristic for any psychotic disorder is loosing the reality control. Understanding 
the reality and sharing the same view on reality with other members of the same culture has 
a strong developmental basis. Young children cannot distinguish between fantasy and 
reality (Remschmidt, 2001). Therefore, it is extremely difficult to demonstrate psychotic 
processes until children develop reasonably cognitive and linguistic abilities. Beliefs in 
fantasy figures, imaginary friends are common in preschool children. Transient psychotic-
like symptoms, such as hallucinations, can be thus observed in preschool children in relation 
to stress and anxiety (Rothstein, 1981). Children under 4 years cannot develop typical 
psychotic symptoms (delusions of persecution or influence) because they lack a fully formed 
perception of social relations (Remschmidt, 2004). 
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In school children, psychotic phenomena are not common, but if they are present, they show 
the tendency to persist and are frequently associated with schizophrenia (Carlson & 
Kashani, 1988; Del Beccaro et al., 1988; Russel et al., 1989; Volkmar et al., 1988). In 
adolescents, the levels of psychotic disorders increase markedly and clinical pictures are 
similar to those seen in the adulthood. Also, the differential diagnosis becomes difficult in 
the adolescence because of frequent substance abuse in this age range and also because of 
increased frequency of brief psychotic episodes associated with other conditions such as 
borderline personality and others (McKenna, 1994). 
5. Childhood and adolescent schizophrenia 
5.1 Epidemiology 
Early-onset schizophrenia can be divided into a very early-onset or childhood-onset 
schizophrenia (major symptoms of schizophrenia are present at or under the age of 12) and 
adolescent-onset schizophrenia (with major symptoms in the 13-19 year age range) (Martin 
& Volkmar, 2007; Remschmidt, 2001). 
The lifetime prevalence of schizophrenia is around 1%. It is very rare before the age of 12 
and it peaks between the age of 13 and 17 (Remschmidt, 1994). The prevalence of early-onset 
schizophrenia (childhood and adolescent schizophrenia) is 0.23%. Only 0.1-1% of 
schizophrenic disorders start before the age of 10, 4% start before the age of 15 and 10% start 
between the age of 16 and 20. According to one population study, adolescent onset 
schizophrenia affects 0.23% of the general population and according to another population 
study, it affects 1.34% of the general population of teenagers with mental retardation 
(Remschmidt, 2001). Before the age of 15, there is a higher proportion of boys (male:female 
ratio is 3:1), but soon after the age of 15 the male:female ratio reaches 1:1 (Remschmidt, 
2004). 
In Europe, childhood-onset schizophrenia is only occasionally diagnosed. An outcome 
study in Germany  covering a 30-year period reported only 40 cases, many of which had 
onset after the age of 10, but before the age of 13 (Eggers,1978). The NIHM childhood-onset 
schizophrenia study, which has been ongoing since 1990 in USA has found 89 cases of 
childhood schizophrenia (Martin &Volkmar, 2007). 
In general, mean IQ in children with schizophrenia seems to be lower than in the general 
population. About 10-20% score about 70 or under. This fact is considered a premorbid 
feature and not a consequence of schizophrenia (Aylward, 1984). The same seems to be true 
for adolescents with schizophrenia. Altogether, 1.34% of them have an IQ under 70, a 
percentage that is much higher than in the general population where it is just 0.23% 
(Remschmidt, 2001 ). 
5.2 Etiology 
Schizophrenia is a complex multifactor disorder, where genetics is an important 
vulnerability factor. The actual occurrence of the disease and its form, however, depend 
upon many other familiar and unfamiliar internal and external ‒ environment factors 
(Sadock & Sadock, 2007). Schizophrenia can thus be seen as a syndrome at the end of 
dynamic processes, which can be explained with neurodevelopment and neurodegenerative 
models. 
Neurodevelopmental model proposes that the biological origins of schizophrenia lie in the 
fetal neurodevelopment, and this early developmental lesion can be traced in premorbid 
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developmental, behavioural and cognitive impairments. This neuropathology is finally 
expressed as classical psychotic symptoms (Purves &Lichtmen, 1980). There is still a lively 
debate about the value of neurodevelopmental model, since not all patients with 
schizophrenia show premorbid abnormalietis. 
In the last 50 years, neurotransmitter (dopaminergic, serotonergic and glutaminergic) 
hypotheses have prevailed in an etiology of schizophrenia. However, neurobiological in-
vivo and post-mortem studies of neurotransmitter system have yielded inconsistent and 
contradictory results rather than providing more precise knowledge of schizophrenia 
etiology. But on the other hand, they were crucial in pharmacotherapy improvement for 
schizophrenia (Haroutunian, 2007). 
Also, in the last decades, it is the genetic studies that have come to the forefront of 
schizophrenia research. Linkage analysis of microsatellite regions in schizophrenic families 
has shown that regions associated with schizophrenia can be found on many chromosomes. 
The impact of one single gene on the disease is very small, probably less than 1% (Gill, 1996; 
Riley, 2006). The second frequently used genetic method is searching for candidate genes for 
schizophrenia (Riley, 2006). Among those that are researched in relation to schizophrenia 
are also the genes that encode dopamine and serotonin receptors and promoters.  
As evidenced by the research, there are no genes that would significantly impact the onset 
of schizophrenia. Instead, schizophrenia seems to be a product of various risk factors in 
people that are genetically sensitive. This sensitivity is complex and it is most likely 
represented by a changing combination of various genes with small impact (Sadock & 
Sadock, 2007). Genetic sensitivity alone, however, is not sufficient for the development of 
the clinical picture of schizophrenia. Other risk factors must be present too (Riley, 2006; 
Prathikanti & Weinberger, 2005). 
It is possible that childhood schizophrenia has a higher genetic loading, since the outcome of 
childhood schizophrenia is very poor and probably much worse than for adolescent- and 
adult-onset schizophrenia (Remschmidt, 2001).  
It seems that multiple gene influences result in continuous dimensions rather than in 
categorical disorders. Thus the dimensional model for schizophrenia seems to be more 
appropriate than the categorical one (dimensional model will be explained in the subchapter 
on Diagnosis). 
Unfortunately, genetic studies too have failed to fully explain schizophrenia etiology. It 
remains vaguely and phenotypically broadly defined disorder that represents a complex 
disease due to the incomplete penetrance and heterogenic genetics (Kendler, 1993; 
Prathikanti & Weinberger, 2005).  
There is, however, a new concept emerging in schizophrenia research, namely 
endophenotypes. Endophenotypes are particularly useful for understanding the etiology of 
complex disorders – such as schizophrenia – in which several genes and environmental factors 
influence the phenotype. Synonyms for endophenotypes are biological markers, biological 
phenotypes, latent phenotypes or intermediate phenotypes (Gottesman, 2003; Gould, 2006; 
Holden, 2003; Preston & Weinberger, 2005; Weinberger, 2002). The endophenotype is less 
genetically complex than the disorder it underlies (Castellanos & Tannock, 2002). It is assumed 
that it is more closely related to one or more pathophysiological genes for the nosological 
category, compared with the entire spectrum of disorders included in the nosological category. 
It is not necessary for an endophenotype to belong to a specific nosological category because 
nosological categories usually do not have biological background. It is, however, necessary for 
it to be heritable and to segregate with illness within families (Berrettini, 2005). Cognitive and 
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biochemical features of psychiatric patients are more associated with genetic factors than the 
behavioural phenotypes. The idea of endophenotypes is basically to relate some features of 
schizophrenic patients to the genes (Gottesman & Gould, 2003; Berrettini, 2005). 
Endophenotypes are stable, state-independent characteristics in contras to behavioural 
symptoms (Berrettini, 2005). The most studied endophenotypes today are cognitive deficits, an 
abnormality of the P50 auditory evoked potential and imagining phenotypes (Berrettini, 2005; 
Burdick et al., 2006; Turner et al., 2006). 
Schizophrenia peaks at the age of 15 and this is one of the reasons why many authors see the 
puberty as a risk factor for schizophrenia (Remschmidt, 2004; Hyde, 1992). Neurobiological 
changes that occur during the puberty and adolescence can influence more frequent 
occurrence of schizophrenia during this period of life. These neurobiological changes are: 
myelinisation of the associative cortex and hippocampus, maturation of the prefrontal 
cortex, diminishing of the cerebral plasticity, effect of sex hormones on synapses 
development and changes in dopaminergic innervations (the last two proved only in 
animals) and changes in neurotransmission (Remschmidt, 2004). 
5.3 Diagnosis  
No symptom or sign is pathognomonic for schizophrenia. Moreover, patient symptoms 
change with time. During the last decade, schizophrenic symptoms have been linked to the 
underlying neurocognitive processes and further to the genetic substrate (for detail please 
see subchapter on Eetiology – Endophenotypes). It seems that multiple gene influences 
result in continuous dimensions rather than in categorical disorders. For schizophrenia, five 
symptom dimensions can be described (positive, negative, disorganized, cognitive and 
affective symptoms). 
Positive symptoms  
- Hallucinations, which can be auditory, visual, somatic-tactile, and olfactory. Typical for 
schizophrenia are voices commenting and/or conversing patient’s behaviour or 
commending him or her what to do (imperative hallucinations). 
- Delusions, which can be persecutory, jealousy, guilt and sin, grandiose, religious, and 
somatic. Typical for patients with schizophrenia are delusions of reference, of being 
controlled, of mind reading, though broadcasting and thought withdrawal. 
- Positive formal thought disorder like distractible speech, pressure of speech, illogicality, 
and derailment. Some authors classified some of these symptoms among disorganized 
symptoms. 
Negative symptoms 
- Affective flattening, which can be seen as unchanged facial expression no matter the 
circumstances, decreased spontaneous movements, paucity of expressive gestures, and 
poor eye contact etc. 
- Alogia (poverty of speech, poverty of content of speech, blocking, and increased 
response latency). 
- Avolition-apathy (grooming and hygiene, impersistence at work or school, physical 
anergia). 
- Attention (social inattentiveness and inattentiveness during testing). 
Disorganized symptoms 
- Bizarre behaviour, including bizarre clothing and appearance, social and sexual 
behaviour, giggling for no reason, aggressive or agitated behaviour and repetitive or 
stereotyped behaviour. 
www.intechopen.com
 
Psychiatric Disorders – Trends and Developments 
 
136 
- Disorganized thinking with illogical, nonsensical thought patterns jumping from one 
unrelated idea to another, so that it is impossible to understand what the person is 
trying to say. Making up words is common.  
Cognitive symptoms refer to the difficulties with concentration and memory. Thy may 
include:  
- slow thinking  
- difficulty understanding 
- poor concentration  
- poor memory  
- difficulty expressing thoughts  
- difficulty integrating thoughts, feelings and behaviour.  
5.3.1 DSM-IV diagnostic criteria (Diagnostic and Statistical Manual of mental 
disorders)  
DSM-IV (American Psychiatric Association, 1994) contains the American Psychiatric 
Association’s official diagnostic criteria for schizophrenia, which describes several types of 
schizophrenia. The presence of hallucinations or delusions is not necessary for the diagnosis 
of schizophrenia. A patient’s disorder is diagnosed as schizophrenia also when the two of 
the symptoms listed as symptoms 3-5 in criterion A are present. 
Criterion A characteristic symptoms: two or more of the following, each present for a 
significant portion of time during a 1-month period (or less if successfully treated): 
1. delusions 
2. hallucinations 
3. disorganized speech 
4. grossly disorganized or catatonic behaviour 
5. negative symptoms. 
For a significant portion of the time since the onset of the disturbance, one or more major 
areas of functioning such as school or work must be markedly below the level achieved 
prior to the onset of the disturbance to fulfil the diagnostic criteria for schizophrenia. 
Continuous symptoms of the disturbance have to persist for at least 6 months. Prodromal 
symptoms are included in this 6-month period. At least 1 month of acute symptoms (or less 
if successfully treated) has to be present for the diagnosis of schizophrenia. Schizoaffective 
disorder, mood disorder with psychotic features, pervasive developmental disorder, direct 
physiological effects of a substance (a drug abuse, a medication) or a general medical 
condition have to be ruled out.  
DSM-IV advocates the application of the same diagnostic criteria in early-onset 
schizophrenia as for adult-type disorders with some allowance for different manifestations. 
It recognises several different types of schizophrenia. 
5.3.1.1. Paranoid type is the most common type of schizophrenia, typically beginning in adult 
life. It is the prototype of positive symptoms. The course of disease usually does not lead to 
personality and cognitive changes (Sadock & Sadock, 2007; Remschmidt, 2005). 
5.3.1.2 Disorganized type (also cold hebephrenic type) begins most often in puberty with an 
insidious, slow and unspecific onset. It can often be mistaken for an adolescent crisis. This 
type is characterized by a marked regression to a primitive, disinhibited and disorganized 
behaviour. Depersonalization phenomena can be present. The contact with reality is poor, 
the emotional responses are inappropriate. They can burst into laughter without any 
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apparent reason. Incongruous grinning and grimacing is also common. The behaviour can 
be described as silly or fatuous (Sadock & Sadock, 2007; Remschmidt, 2005). These patients 
are usually intelligent with the premorbid personality characteristics such as shyness, 
passiveness, introverted, with few/no friends. This type can be diagnosed after a few 
months of observations. Patients with disorganized type show negative symptomatics early 
in the course of disease. This is also the reason why this type is a prototype for negative 
symptoms (Remschmidt, 2005). 
5.3.1.3 Catatonic type was common several decades ago. In Europe and North America, it is 
quite rare today, most likely because of the antipsychotic treatment. The classic feature is a 
marked disturbance in motor function which can involve stupor, negativism, rigidity, 
excitement or posturing. Rapid alternations from one extreme (stupor) to another 
(excitement) are also possible (Sandock & Sandock, 2007). 
5.3.1.4 Residual type is a chronic state characterized by the presence of continuing evidence of 
the schizophrenic disturbance in the absence of a complete set of active symptoms or 
sufficient symptoms to meet the diagnosis of another type of schizophrenia. Emotional 
blunting, social withdrawal, eccentric behaviour, illogical thinking and mild loosing of 
associations commonly appear. Hallucinations or delusions can be present from time to time 
but are neither prominent nor accompanied with a strong affect (Sandock & Sandock, 2007). 
5.3.1.5 Undifferentiated type is a type characterized by the presence of symptoms for 
schizophrenia, but does not meet criteria for any other type. 
5.3.1.6 Simple schizophrenia is a type of schizophrenia according to ICD-10 classification 
(International Statistical Classification of Diseases and Related Health Problems, 1993) with 
particular insidious onset of withdrawal and social deterioration associated with very poor 
outcome. It usually starts slowly and untypically in adolescence. In the absence of 
prominent delusions, hallucinations or disorganized speech, it leads to a profound personal 
and social destruction. Patients are depressed, anhedonic, without energy and/or 
motivation. They can leave a school or a job and many of them can be found in marginal 
populations (homeless etc.). The diagnosing of this type can be quite difficult, since it is not 
clearly demarcated neither from the schizoid nor from the schizotypal personality disorder 
(Remschmidt, 2005). 
In early-onset schizophrenia there are typically fewer well-formed systematized types when 
compared to adult schizophrenia. It appears that there is a relative predominance of 
disorganised and undifferentiated cases and fewer paranoid cases in early-onset 
schizophrenia, when compared with adult schizophrenia (Remschmidt, 2001). 
The definition of schizophrenia is symptom based, so the diagnostic criteria using the adult 
manifestation of the disorder could miss some of the developmental variability in symptoms 
seen in children and adolescents. This could result in missed diagnoses, especially in 
presentation with a slow onset and negative symptoms, which are more commonly seen in 
children and adolescents (Remschmidt, 2001). 
Another factor that has to be taken into consideration is the patient’s age, which has a strong 
impact on the schizophrenic symptom types. Positive symptoms increase linearly with age, 
while the negative ones occur most frequently in the early childhood and late adolescence 
(Remschmidt, 2004). Bettes and Walker found a correlation between symptoms and IQ: 
children with high IQ showed more positive and fewer negative symptoms than low-IQ 
children (Bettes & Walker, 1987). In the course of schizophrenic symptomatology, there is a 
clear shift from positive and mixed symptoms to negative ones, which correlates with 
disease chronicity (Remschmidt, 2005).  
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Slow and insidious onset of childhood and adolescent schizophrenia is a rule rather than an 
exception. This is the reason why cases of early-onset schizophrenia are diagnosed with up 
to two-year delay (Schefer & Ross, 2002). Such delays worsen the course and prognosis of 
the disease, so early diagnosis and treatment is crucial. Early-onset schizophrenia with acute 
onset, on the other hand, poses less problems, mostly due to easily recognisable positive 
symptoms.  
5.3.2 Other possible diagnostic aspects 
An interesting feature of early-onset schizophrenia compared to adult one seems to be the 
higher rates of early language, social and motor developmental abnormalities, which are 
possibly reflecting greater impairment in early brain development (Martin & Volkmar, 
2007). This is the reason why Werry suggests at least two clinical phenotypes of 
schizophrenia. The first one is associated with a long-standing developmental abnormality 
where the acute psychotic episode develops after some years of pre-existing abnormality. 
The second phenotype develops in children and adolescents who have had previously 
normal development (Werry, 1996). 
Schizophrenic symptomatic in children and adolescents as well as in adults can also be 
described using another distinction which differentiates between two type of 
schizophrenia differing in psychopathological symptoms and premorbid functioning of 
the patient (Remschmidt, 2005). Type I is characterized by positive symptoms – 
hallucinations and illusions. Patients are aggressive, restless and excited, they can talk a 
lot and can make up new words (neologisms). The CAT scan usually reveals a normal 
brain structure and the response to the pharmacological treatment is usually good. Type 
II, on the other hand, is characterized by negative symptoms – affective flattening, social 
withdrawal, loss of interests and cognitive slowness. Here, the CAT scan shows brain 
structural changes and the response to pharmacotherapy is worse than in type I (Kaplan 
& Sadock, 1998).  
5.4 Preclinical symptoms and associated features 
5.4.1 Prodromal states 
Before full symptoms of schizophrenia are manifested in a clinical picture, disease pre-stage 
– prodromal state can be present in 75% of patients with schizophrenia. Prodromal state can 
last a few days or some years (Remschmidt, 2005). The symptoms are unspecific, ranging 
from problems with concentration, changes in motivation and sleep disturbances, unspecific 
fears, irritability and suspiciousness. Family and friends may notice that the person has 
changed and is no longer functioning well in social, school and/or occupational activities. A 
patient may develop an interest in abstract ideas, philosophy and in the occult and religious 
questions. Peculiar behaviour, abnormal affects, unusual speech, bizarre ideas and strange 
perceptual experiences can be present too. Somatic complains such as headache, back and 
muscle pain, weakness and digestive problems can also be seen in prodromal state (Sadock 
& Sadock, 2007). Unspecific prodromal state could be misdiagnosed as adolescent crises or 
same other psychiatric diagnosis. 
Negative symptoms are usually the first schizophrenic symptoms present in a prodromal 
state, while positive ones usually appear later during the acute state of schizophrenia 
(Remschmidt, 2005). 
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5.4.2 Premorbid personality characteristics 
Typical, but not invariable, for some children and adolescents with schizophrenia are their 
premorbid personality characteristics. They are usually quite passive, introverted with few 
or no friends. They may avoid sport and social activities such as dating and watch TV or 
listen to the music instead. As children they are often described as special, perpetually 
unsatisfied and sensitive. Described characteristics may be detected in half of the children 
and adolescents with schizophrenia (Remschmidt, 2005). 
5.4.3 Unspecific developmental abnormalities 
In addition to prodromal state and premorbid personality characteristics, patients with early-
onset schizophrenia can also show many unspecific developmental abnormalities such as soft 
neurological signs, unspecific sensory and motoric neurological abnormalities, aggravated 
autonomic reactions, different perinatal complications and symptoms of hyperkinetic 
syndrome (Remschmidt, 2004). Prevalent findings in a personal history of children and 
adolescents with schizophrenia are also cognitive impairments, lower IQ, transient symptoms 
of pervasive disorder and social withdrawal. A study of Alaghband-Rad et al. found that 36% 
of patients with childhood schizophrenia had a premorbid history of at least one pervasive 
developmental disorder feature and 13% had full autism (Alaghband-Rad et al., 1995). In all, 
60-70% of children with childhood onset schizophrenia had language and/or motor 
impairments in infancy (Jacobsen & Rapoport, 1998; Watkins et al., 1988). All described 
features and impairments are not specific for early-onset schizophrenia, they can also be found 
in other psychiatric disorders, so they have no diagnostic value. 
There is a vivid debate on primary prevention for subjects at high risk for schizophrenia. In 
short, our knowledge today is not sufficient enough to reliably diagnose pre-schizophrenic 
states, which is why preventive pharmacological treatment cannot be recommended as yet. 
5.5 Course and prognosis 
Early-onset schizophrenia has worse prognosis compared to schizophrenia occurring in 
adulthood. Only 23% of patients with early-onset schizophrenia reach full remission 
(compared to 25% of adult patients), while 25% of them reach partial remission (compared 
to 50% of adult patients). Chronic course will have 52% of patients with early-onset 
schizophrenia (compared to 25% of adult patients) (Remschmidt, 2005). After the 
hospitalization, 40% of patients with early-onset schizophrenia cannot go back to the same 
educational/professional level as before the hospitalization. Besides the chronicification of 
the disease, disfunctional family environment may also be the reason (Remschmidt, 2005).  
Moreover, a total of 10% of people with adult schizophrenia die by suicide (Kaplan & 
Sadock, 1998). There are not many studies on this topic in children and adolescents, but one 
provides interesting results. Eggers points to the risk of suicide in the prodromal state and 
growing suicidal risk with onset of schizophrenia; where 65% of adolescents were 
preoccupied by death thoughts, 20% attempted suicide and 5% committed suicide. 
Compared to adults, suicide was relatively late phenomena, with the average time of 8.5 
years between the onset of schizophrenia and the attempted suicide, and the average time 
between 6 and 14 years for the committed suicide (Eggers, 1978).  
In general, the prognosis for the early-onset schizophrenia is as follows: the earlier the onset, 
the greater the disability (Remschmidt, 2001). Regarding the gender, girls seem to have 
somewhat better prognosis, both because they seem to be less vulnerable to the early-onset 
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than boys, and because they seem to be less affected by the illness. This, however, does not 
mean that their chance of full recovery is any better than in boys. 
Studies show that children with prodromal state that lasted over one year have worse 
prognosis for clinical improvement during hospitalization (Amminger et al., 1997). 
5.6 Differential diagnosis 
5.6.1 Conduct and emotional disorders 
Hallucination can be present in conduct and emotional disorders, particularly at the times of 
stress. When focusing on persecutory ideas and ideas of reference, which are often present 
in conduct and emotional disorders, the misdiagnosis can be the problem (Remschmidt, 
2001). 
5.6.2 Affective psychosis 
In a follow-up study of Werry, over 50% of the bipolar disorder cases had initial diagnosis of 
schizophrenia (Werry, 1991), which makes a valid distinction between schizophrenia and 
bipolar disorder in children and adolescents questionable. In affective psychosis, however, 
the onset of psychotic symptoms is often rapid with relatively good premorbid social and 
school functioning. 
5.6.3 Autistic spectrum disorders 
Positive symptoms may develop in autistic spectrum disorders in adolescence, however, 
they are usually transitory. Children and adolescents with autistic spectrum disorders have 
more long-standing and progressive deterioration in social and cognitive fields prior to the 
onset of psychotic symptoms. 
5.6.4 Organic brain conditions 
At first episode of schizophrenia, one must exclude all other possible organic causes for 
psychotic symptomatology (drug-inducted psychosis, epilepsy, neuro-degenerative 
disorders etc.) described in special subchapters.  
5.7 Treatment of schizophrenia 
5.7.1 Pharmacological treatment 
Antipsychotics are the first choice drugs in a pharmacological treatment of schizophrenia. 
They act suppressively on the symptomatology of the disease, but do not cure the disease. 
They calm, reduce and eliminate psychotic symptoms in an acute state of schizophrenia. 
When the acute state has settled down, they act prophylactic against psychotic recidives. 
Pharmacological treatment in schizophrenia can be divided into three phases: 
- Acute phase, in which antipsychotics act suppressively on major schizophrenic 
symptoms. 
- Maintenance phase, which starts in full remission and should last at least six months 
with the same doses of antiphsychotics as in acute phase. The purpose is to prevent 
possible relapse, to improve patient’s social skills and further relief of symptoms.  
- Prophylaxis phase prevents recidive and helps maintaining and/or exceeding the 
achieved level of patient’s functioning and quality of life. This phase should last at least 
one year after the first episode of schizophrenia and several years after the second 
episode of schizophrenia. As schizophrenia is a chronic disease, the pharmacological 
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treatment can be lifelong. The doses of antipsychotics should be lower than in the first 
two phases (Sandock & Sandock, 2007).  
5.7.2 Psychotherapeutic measures 
It is crucial that schizophrenic patients and their families are educated about the disease, its 
etiology, its course and the treatment. Patients and their families have to have the 
knowledge about the disorder in order to recognise a relapse on time, to prevent preterm 
drug reduction or cessation, and to strengthen the compliance. Among psychotherapeutic 
measures, only the most used/applied will be mentioned, i.e. cognitive and other 
behavioural approaches, emotion management therapy, group programs, family-oriented 
measures, supportive and structural family therapy and extended development-oriented 
family therapy. 
5.7.3 Rehabilitation 
Since nearly half of the patients suffering from schizophrenia cannot return immediately 
after the hospitalization to their school/occupational and family environment, they are 
usually directed to rehabilitation centres. On average, the rehabilitation lasts two years and 
is crucial to the treatment of schizophrenia.  
The rehabilitation can be divided into two phases, aiming at growing stepwise 
independence. During the first phase, much effort should be assigned to the areas of 
schooling, working skills, social skills training and interpersonal problem solving. It usually 
lasts one year. The patient is living together with other patients in a rehabilitation centre in a 
family-like structured program. The second rehabilitation phase, however, should bring 
major change to the patient in order to gain more independence, self-sufficiency, 
psychosocial reintegration and the continuation of school and professional work without the 
significant support from the rehabilitation centre (Remschmidt, 2001). 
6. Acute and transient psychotic disorders  
There are no reliable data on incidence and prevalence, gender ratio and the mean age at the 
onset for this psychotic disorder. It seems, however, that it is more frequent in a younger 
population. The disorder is characterized by a sudden onset (less than in a two-week time) 
of psychotic symptoms, which may include delusions, hallucinations, disorganized speech 
or behavior, or catatonic behavior. Also, the symptoms can change frequently during an 
episode. The duration of an acute and transient psychosis is generally short, non re-
occurring, and not better accounted for by another condition. Symptoms generally do not 
last long, usually just a few days or weeks, but 2-3 months at most. There is a possibility of 
an eventual return to full baseline functioning (Kaplan & Sadock, 1998). The prognosis is 
good ‒ 50-80% of patients do not have any psychiatric problems after the acute psychosis 
has ended. Occasionally, a relation to a stressor can be found. In such cases, the diagnosis of 
a reactive disorder is appropriate (Sandock & Sandock, 2007). 
6.1 Reactive psychoses 
Reactive psychosis occurs shortly after (maximum 2 weeks after) and in response to a 
significant stressor in a person's life (death in the family, war, divorce, abuse, etc.). Psychotic 
symptoms can be thematically closely related to the trauma. The reactive psychoses are 
short. Their duration is usually not longer than 2-3 months. 
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7. Substance-induced psychotic disorder 
There are 3 facts that are important when dealing with psychoactive substances associated 
with psychotic disorders (Kaplan & Sadock, 1998; Remschmidt, 2004). 
- Psychoactive substances can cause psychotic symptoms in anyone (typical 
hallucinogens are LSD, phencyclidine ‒”angel dust”, cocaine and amphetamine ‒ ”speed” 
and ”ecstasy”).  
- In a person who is genetically predisposed to developing a psychosis, psychoactive 
substances can accelerate the onset of the psychosis and worsen its clinical picture, 
course and treatment. 
- Patients with psychotic disorder (most often schizophrenia) can use psychoactive 
substances as self-medication because of their effect on symptomatic recovery. Heroin, 
for instance, can reduce hallucinations, while cannabis, on the other hand, calms the 
psychotic excitement.  
Psychotic symptoms in substance-induced psychotic disorders develop during the intake of 
a substance or not later than 48 hours after it. Partial remission occurs within one month, 
while full remission is achieved in 6 months (Remschmidt, 2004). Prominent hallucinations 
(they typically appear on more than one sensorial level, even though acoustic hallucinations 
are the most frequent ones), delusions, psychomotor abnormalities (excitment or stupor) 
and a variety of affective symptoms are typical for a substance-induced psychotic disorder. 
It is worth mentioning that canabis can cause chronic psychotic state too (Sandock & 
Sandock, 2007).  
In an acute psychotic state, it is difficult to make a distinction between substance-induced 
psychotic disorders, brief and acute psychotic disorders and schizophrenia. The main facts 
that militate against the substance-induced psychotic disorders are (Remschmidt, 2005): 
- The presence of psychotic symptoms prior to the drug consummation.  
- The presence of psychotic episodes prior to the drug consummation. 
- Drug-induced psychotic symptoms persist longer than expected.  
8. Psychotic disorders due to general medical condition 
The evaluation of a psychotic patient requires also a consideration of the possibility that the 
psychotic symptoms are the result of a general medical condition (brain tumour, head 
injury, poisoning, infection, metabolic diseases, epilepsy, etc.). These conditions can 
represent a real diagnostic problem if the psychotic symptoms are the only symptoms in the 
clinical picture. In such a case, there is a danger to overlook the organic/somatic cause of the 
symptomatology and to treat the patient incorrectly. When dealing with a case of first 
psychotic/schizophrenic episode there is a need to preform  laboratory tests and imaging 
investigations in order to exclude the most possible causes of psychotic symptomatology 
(Sandock & Sandock, 2007). 
8.1 Case report 
An 18-year-old girl was admitted to the Child and Adolescent Psychiatry Unit of the 
Maribor University Clinical Centre in Slovenia for suspected disorganized (formerly called 
hebephrenic) schizophrenia. A year before that, at the age of 17, she had begun to laugh 
without reason, and her behaviour had become silly and disorganized. Her emotional 
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responses were inappropriate. She started grimacing and became paramimic and 
parathymic. She withdrew socially and began to shut herself in her room. She had auditory 
hallucinations, consisting of a running commentary on her behaviour. At that time, there 
were no changes in her school performance, which was already consistently below average; 
however, her school performance deteriorated 3 months before admission to hospital, when 
she became unable to do any schoolwork. She also became disoriented as to her 
whereabouts and got lost several times. 
There had been no aberrations in her developmental milestones. Until recently, she had not 
had any diseases or needed any medical attention. 
Her family history was interesting. She had a 24-year-old brother with moderate mental 
retardation according to the DSM-IV criteria. He had delayed developmental milestones and 
difficulties in walking and speaking. She also had a 25-year-old sister who, 4 years before, 
had had an episode of postpartum depression (according to DSM-IV criteria) that started a 
few days after she had delivered a baby. She had depressed mood and no interest in her 
baby or in any other activities. She was motor retarded, complained about loss of energy 
and diminished ability to think and concentrate, and she reported feelings of worthlessness 
and guilt about being ill and not being able to take care of her baby. She cried constantly, 
had no appetite and suffered from insomnia. She recovered in a month without any 
antidepressants. Her school performance had been below average throughout all 10 years of 
her education, and she had been unable to find a job either before or after the episode of 
postpartum depression. She attended night school to become a cook and had achieved 
average success at the time of writing. There was no history of psychiatric disturbance 
before or after the episode of postpartum depression. The patient’s mother had 7 half-
siblings. Two had died, probably of pneumonia, at the age of 6 months. The third sibling 
was mentally retarded and probably had poliomyelitis at the age of 2 years. Otherwise, 
there was no family history of psychiatric disorders. 
At admission, our patient was disoriented in terms of time, place and person. Her thought 
process was disorganized, and her behaviour was disorganized and uninhibited. She was 
paramimic and parathymic with blunted affect. Her rapport with others was poor and her 
speech monotonous, and her understanding of questions was poor. She had a poor attention 
span and reported auditory hallucinations, consisting of a running commentary on her 
behaviour, which she found pleasant. She described the hallucinations as a single young 
male voice, which was talking to her using short sentences, mostly encouraging her to do 
everyday tasks and commenting on her behaviour. She revealed a lack of initiative, had 
poor contact with reality and had no insight into her illness. She was incontinent of urine 
and had dyspraxia. Psychological tests (Rorschach projective test and Bender Visual–Motor 
Gestalt test) revealed psychotic disturbance. The results of routine laboratory tests including 
thyroid-stimulating hormone, vitamin B12 and folic acid were normal. The findings of 
syphilis and HIV-1 serology were negative, as was serology for Borrelia burgdorferi. Levels 
of proteins in the cerebrospinal fluid were elevated (0.77 g/L). Electroencephalography 
(EEG) showed abnormal bilateral synchronous, mainly theta activity, which was most 
prominent temporally. 
According to DSM-IV diagnostic criteria, the patient’s disease presented like disorganized 
schizophrenia (disorganized thought process and behaviour, flattening of the affect, 
auditory hallucinations and social dysfunction). These symptoms persisted for about 9 
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months without any marked signs of cognitive impairment, apart from poor attention and 
slowing in thought process. Therefore, treatment with small doses of an atypical 
antipsychotic, risperidone (1 mL twice a day) was initiated. 
After 1 week of treatment, the patient stopped reporting auditory hallucinations. 
Although her behaviour was still disorganized, she was more willing to cooperate during 
the required medical examinations. Neurologic examination revealed positive pyramidal 
signs in the upper extremities. Tendon-stretch reflexes in the lower extremities were 
absent distally. Computed tomography revealed signs of advanced cortical atrophy, 
symmetrical ventricular enlargement and periventricular white-matter hypodensity. 
Magnetic resonance imaging of the brain showed diffuse signal hyperintensity of the 
white matter, especially in the periventricular area, as well as in the corpus callosum, 
cerebral atrophic changes and symmetrical ventricular enlargement. Electromyography 
showed a slowing of the nerve conduction velocities (NCV) (NCV of the peroneal nerve 
was 23 m/s [reference range 44–57 m/s]) and marked prolongation of the F-wave latency. 
Visual evoked potentials showed a normal retinogram, but cortical responses had 
prolonged latencies with a normal response distribution. Somatosensory and acoustic 
evoked potentials were within normal limits. Abdominal ultrasonography revealed 
polyposis of the gall bladder. 
Four weeks later, the disorganized and psychotic clinical picture diminished and the 
patient’s cognitive impairment became increasingly obvious. Apart from poor attention and 
slowing of the thought process, memory (recollection and recent past) was disturbed the 
most. Therefore neuropsychological tests (Wechsler Intelligence Scale, Wechsler Memory 
Scale, Trail-making Test, Stroop Test, Hooper Visual Organization Test, Rivermead 
Behavioural Memory Test and the Controlled Oral Word Association Test) were carried out. 
The patients’ full-scale IQ fell to within the range of severe mental retardation (according to 
DSM-IV criteria). There was a minor difference between the patient’s verbal and 
performance IQ, favouring the former. The impairments were severe over the whole range 
of mental functioning. Attention processes, perception, executive functions, communication 
and motor skills were impaired. Her processing speed was very slow. Memory for verbally 
presented information and visual memory were found to be severely impaired. She could 
not independently perform any simple or routine operations. Therefore, an 
acetylcholinesterase (AChE) inhibitor was added to the therapy (galantamine, 4 mg, twice a 
day for 1 month, then galantamine, 8 mg, twice a day). 
Taking into account the diagnostic findings of neurologic examinations, neuropsychological 
tests, urinary incontinence and imaging, it was clear that there was most probably an 
organic disorder underlying the disorganized schizophrenia–like symptoms, which also 
later caused symptoms of dementia. Therefore, further tests were performed, focusing 
especially on inherited metabolic disorders. 
The results of urine screening tests and screening for very long chain fatty acids in the 
serum were normal, excluding adrenoleukodystrophy and several disorders of peroxisomal 
function. Arylsulfatase A activity in leukocytes was markedly reduced (0.047 nmol/h per 
milligram; normal values in controls 2.82 ± 1.24 nmol/h per milligram). Measurement of 
urinary sulfatides by electrospray ionization–tandem mass spectrometry showed a 10-fold 
elevation of 609 nmol/L (values in healthy controls 51.5 ± 33.45 nmol/L), thus confirming 
the diagnosis of metachrometic leukodystrophia (MLD). 
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In the patient’s sister, who remained clinically asymptomatic apart from the single episode 
described earlier, biochemical tests also showed clear arylsulfatase, a deficiency in 
leukocytes (0.155 nmol/h per milligram) and markedly elevated sulfatides in urine (436 
nmol/L), thus proving the presence of a metabolic disease metachrometic leukodystrophy 
(MLD). In accordance with their obligate heterozygosity, intermediate arylsulfatase A 
activity was found in both of our patients’ parents. Our patients’ mentally retarded older 
brother had normal arylsulfatase A activity and normal values of sulfatides in the urine.  
8.2 Discussion 
Metachromatic leukodystrophy is one of the most serious genetic demyelination disorders 
(Tylki-Szymanska et al., 1996). It is an autosomal recessive lysosomal disease characterized 
by demyelination of the white matter in the central nervous system and the peripheral 
nerves. The relevant gene is located on chromosome 22q13. The disease is caused by a 
deficiency of the enzyme arylsulfatase A, which hydrolyzes various sulfatides, including the 
major sulfate-containing lipids of the nervous system. Sulfatide accumulation can be found 
in the brain and peripheral nerves and nonneural organs (kidney and gallbladder) 
(Hageman et al., 1995). The incidence of MLD is estimated between 1 and 5 cases per 100 000 
newborns (Rentrop et al., 1999) 
There are 3 types of MLD: late infantile, juvenile and adult. The late-infantile form, which 
has its onset at the age of 1–2 years, is characterized by gait and behavioural disturbances. 
The course of the disease is rapid and the outcome fatal. The juvenile form, which has its 
onset between the ages of 3 and 15 years, displays a less distinct phenotype, varying from 
peripheral nerve involvement in younger children to learning problems and behavioural 
difficulties in older children (Kaye, 2001). It has a more protracted course. The symptoms 
of adult MLD include dementia, psychosis, behavioural abnormalities, ataxia, 
polyneuropathy and epileptic seizures. Other psychiatric disorders can present with the 
following MLD symptoms: personality changes, depressive disorders, alcohol addiction, 
and worsening of school and/or work performance. Adult MLD has a slowly progressive 
course. Compared with the late-infantile and juvenile forms, the adult variant of MLD 
appears to be quite rare. The mean survival for adult MLD is at least 12 years, which is 
longer than the survival in late-infantile MLD (3–4 years) and juvenile MLD (7–9 years) 
(Kaye, 2001). 
The diagnosis of MLD is based on arylsulfatase A activity in leukocytes or fibroblasts and on 
sulfatide excretion in the urine.  
There is much disagreement in the literature regarding the incidence of psychosis in  
adult MLD. Hyde et al. (Hyde et al., 1992) suggested that in 53% of patients with adult  
MLD psychosis is present and is often the initial manifestation. Cengiz et al. (Cengiz et al., 
2002) reported the cases of 3 sisters with adult type MLD, 2 of whom were initially 
diagnosed as having schizophrenia. Hageman et al state that psychosis is a less common 
symptom than previously suggested. In their group of 13 patients with confirmed adult 
MLD, the most common symptoms were ataxia and behavioural abnormalities with only 1 
patient suffering from psychosis. The findings were similar in the group of 24 patients with 
confirmed MLD described in the literature, among whom only 4 were psychotic (Hageman 
et al., 1995). 
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Disorganized schizophrenia-like symptoms were the initial manifestation of MLD in our 
patient, and they persisted without any marked signs of cognitive impairment for at least 9 
months. Then she got lost several times, and her school performance deteriorated. It is open 
to discussion whether her school performance deteriorated because of the disorganized 
schizophrenia-like symptoms or whether this was the first symptom of dementia. The 
differential diagnosis of dementia became problematic when disorganized and psychotic 
symptoms diminished after treatment with antipsychotics. We wondered whether 
disorganized schizophrenia-like symptoms just masked dementia? The first symptoms of 
disease were disorganized and silly behaviour, disorganized thought process, inappropriate 
affect, social withdrawal, incongruous grimacing, outbursts of laughter without any 
apparent reason, paramimia, parathymia, auditory hallucinations, poor contact with reality 
and no prominent signs of cognitive impairment. All these symptoms can also be found 
with dementia; however, they usually occur later, have a gradual onset and are rarely all 
present at the same time. At some point, as MLD progressed, disorganized schizophrenia–
like symptoms most probably masked dementia, but dementia was not the initial 
manifestation of MLD in our patient.  
The patient’s older sister, in whom the diagnosis of MLD was confirmed biochemically, had 
had an episode of postpartum depression 4 years before. The literature describes some cases 
of adult MLD manifesting as major depression, but to our knowledge none of postpartum 
depression (Ricketts et al., 1996; Vella et al., 1998). 
Little is known about the symptomatic treatment of psychotic symptoms and dementia in 
MLD. Our patient responded well to treatment with small doses of an atypical 
antipsychotic, showing no side effects. More questionable is the treatment with AChE 
inhibitors, which is only indicated in Alzheimer’s disease. 
This report underlines the importance of metabolic or any other somatic disease as a cause 
of what appears to be a psychosis or schizophrenia. It is crucial to always bear in mind that a 
full clinical, biochemical and imaging diagnostic evaluations must be performed in any 
patient with psychotic symptoms (Seidl et al., 1981). 
9. Treatment of psychotic disorders 
In diagnosing psychosis or any other psychiatric disorder it is important to know how to 
talk to a child or an adolescent. The communication has to be age appropriate, clear and 
without any questions that could be misunderstood or confusing. To create a positive 
transfer it can be helpful to know the topics, films, toys and plays that are popular in a 
specific age group. Children and adolescents usually like to talk openly without any 
reservations. They are frank in their answers and compared to adults they minimalize or 
deny their problems and fears less frequently.  
It is equally important that the therapist is calm and relaxed, using short and 
understandable questions, talking slowly and understandably. Unclear question 
formulations and irony, must be avoided because they can additionally confuse and excite 
the patient. Furthermore, the therapist should also clearly explain the patient that he or 
she is here to help and that in order to do so some questions need to be answered. 
Discussion about the (un)reality of patient’s symptoms and feelings when dealing with an 
acute psychotic patient should be postponed until the remission phase. It is possible that 
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patient’s state of disease will not allow interviewing the patient what have to be 
recognised soon enough in order not to excite the patients further. But general are 
psychotic children and adolescents willing to talk about themselves and their 
symptomatic. 
When meeting an acute psychotic patient for a first time, it is difficult to know if the 
psychotic symptomatics is substance-induced, if it is a result of a general medical condition 
or whether it is a case of schizophrenia. If the patient’s condition allows taking auto- and 
hetero- anamnestic data, these could be very helpful in further differential diagnostic 
considerations. For instance, any information on the febrile state or a head injury is very 
probably associated with a possible organic background. Information on drug consumption 
is needed to exclude or include a substance-induced psychotic disorders in the diagnosis. 
Also, schizophrenia positive family history, a symptomatic that is typical for prodromal 
state or premorbid personal characteristic can be frequently found in the first schizophrenic 
episode. 
Recommended investigations in any first psychotic episode are (Sandock & Sandock, 2007): 
- blood biochemical tests (including liver functional tests), thyroid hormones  
- drug and alcohol tests 
- EEG, ECG, brain imagining investigations (CAT scan or MRI). 
If metabolic diseases are suspicious further diagnostic testing should be performed: lactate, 
pyruvate, ammonia test, aminoacids in serum and urine, organic acids in urine; copper, 
ceruloplasmine (Mb Wilson); encime arylsulphatase A activity in leukocytes and 
sulphatides in urine (metachrometic leukodystrophia) (Gregoric Kumperscak, 2005). 
Roughly speaking, psychotic patients can clinically present as two different types. Firstly, as 
acute psychotic, excited and/or physically aggressive patients with vivid hallucinations and 
illusions without any reality or impulse control and without disease insight. Secondly, as 
socially withdrawn adolescents with peculiar ideas and interests, diminished school 
achievements, in whom psychotic symptoms are present but hardly fulfil the needed 
diagnostic criteria for any psychotic disorder. The first type of patients should be 
hospitalized and treated with antipsychotics and other medicaments described in following 
chapter. The second type with a slowly developing clinical picture of psychosis just needs to 
be carefully followed in order to establish a proper diagnosis. Special care should be taken 
as prodromal state can be easily misdiagnosed or overlooked. Therefore, it is of outmost 
importance for the therapist to be familiar with all variations of development and growing 
up. Sometimes the search of adolescents for their identity can be mistakenly considered as a 
prodromal state. Only when there is a big difference between premorbid functioning and 
actual functioning (lower school achievements and social interests), there is a strong 
likelihood of prodromal state. Adolescents in general feel and describe psychotic symptoms 
before they can actually be seen in their behaviour and be objectivised. Thus, children and 
adolescents in a pre-psychotic state often talk about their inner changing, about a strong 
feeling that there is something happening to them, often stating that they are losing control 
and their mind. They are very upset and tense without any genuine reason. 
9.1 Medication in an acute psychotic and/or excited patient  
Acute psychotic and/or excited patients need medication prior to their admission to the 
hospital. Atypical antipsychotics (AA) and/or benzodiazepines (BD) can be used. The 
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recommendations for acute psychotic and excited child or adolescent treatment follow the 
recommendations for adult patients. All doses have to be age-adjusted.  
AAs and BDs are broadly equally effective in sedation, however the effect of BDs can be 
quicker. Sometimes the combination of AAs and BDs is necessary and also more effective 
(Tayler et al., 2009). If the patient is already on AA, then BDs are recommended. If 
substance-induced psychosis is suspicious, then AAs are appropriate (Tayler et al., 2009). 
Before resorting to intramuscular medication (im.), oral medications are always first choice. 
Clinicians have a good experience with risperidone in suspension, which can be given with 
water or tea. Oral risperidone suspension 0.5 to 2ml can be first administrated and if no 
effect is achieved after 2 hours, another dose of risperidone can be given. Olanzepine 5-
10mg or haloperidol 0.05-0.15mg per kg per day can also be administrated. Among BDs, 
lorazepan 1-2 mg or diazepam 5-10mg can be used and the same dose can be repeatedly 
given after 1-2 hours if no effect is noted. The combination of AAs and BDs could also be 
administrated. 
If there is no possibility for oral medication, im. medication must be used. Among AAs, 
olazepine 2.5-10mg im. can be administrated or a first generation antipsychotic haloperidol 
0.025-0.075mg im. per kg per dose. Among BDs, lorazepam 0.05-0.1 mg im. per kg per dose 
or diazepam 0.1mg per kg per dose by slow iv. injection can be administrated. 
10. Conclusion 
To summarize, there are several traps when dealing with children and adolescents who 
present with symptoms suspicious of being psychosis. The above-described case report 
clearly shows that it is possible for an organic disease to present with psychotic symptoms 
only. This, of course, causes problems in accurately diagnosing the disease. Therefore, in 
order not to overlook a possible organic cause in a psychotic clinical picture, a biochemical, 
neurological and imagining tests and procedures must always be performed first. 
Developmental period with its own special characteristics is another factor that needs to be 
considered when establishing the diagnosis. Each developmental state can colour the clinical 
picture differently. It can either overlap or aggravate the psychotic symptoms. For instance, 
it is completely normal for a 5-years old child to have an imaginary friend, but at age of 15 
such friend may indicate pathology. 
Also, adolescence is associated with many developmental tasks such as identity formation, 
independence and autonomy, and development of one’s own view of life. All this, of course, 
brings along at a certain stage of development a detachment from parents, a retreat into 
their own world, as well as changes in the way of thinking and one’s own philosophy, 
which however should not be confused with the schizophrenia prodromes. On the other 
hand, due to their key neurodevelopmental changes, puberty and adolescence represent an 
important risk factor for the development of schizophrenia. Therefore, this should be taken 
into consideration when establishing the correct diagnosis.  
To conclude, though infrequent in childhood, schizophrenia is a major psychiatric disorder 
of adolescence (Remschmidt, 2001). Bearing in mind that early-onset schizophrenia has 
worse prognosis than the adult-onset one, early diagnosis followed by treatment is essential. 
However, in order to diagnose schizophrenia properly, a thorough knowledge of the 
negative and positive symptoms, prodromal state symptom varieties as well of the full 
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range of normal developmental changes is indispensable. Early-onset schizophrenia 
frequently starts with negative symptoms, but schizophrenia is usually recognised only 
when positive symptoms appear in the clinical picture. It also is noteworthy to mention that 
children and adolescents feel the symptoms and describe them much earlier than their effect 
on their behaviour can be objectivised and diagnosed. 
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